Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Large Cell

Explore clinical trials studying Carcinoma, Large Cell. Study availability and eligibility vary by location and protocol.

11 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Carcinoma, Large Cell trial results

Recruiting

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

NCT06908304

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • Centrum Medyczne Pratia Poznan, Poland
  • Oncolab S.R.L. Craiova, Romania
  • Spitalul Clinic Municipal de Urgenta Timisoara/ Clinica de Oncologie Medicala Timișoara, Romania
  • Changhua Christian Hospital (CCH) Changhua, Taiwan
View all 15 locations
View Trial Details
Completed

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

NCT02737501

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +17 more
Locations
  • USOR - Arizona Oncology Associates - Sedona Sedona, Arizona, United States
  • Kaiser Permanente Bellflower Medical Offices Bellflower, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers - Boulder Boulder, Colorado, United States
View all 91 locations
View Trial Details
Completed

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

NCT02151149

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +17 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
View all 55 locations
View Trial Details
Completed

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

NCT01317615

Conditions
Carcinoma, Carcinoma, Large Cell, Lung Diseases, +12 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Bremen, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Essen, Germany
View Trial Details
Completed

A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer

NCT01362400

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +14 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • PMK Medical Group, Inc. Oxnard, California, United States
View all 65 locations
View Trial Details
Completed

An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

NCT00054899

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Cancer Centers of Florida Orlando, Florida, United States
  • New York Oncology Hematology Albany, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions